CCCC
Price
$2.55
Change
-$0.03 (-1.16%)
Updated
Aug 28 closing price
Capitalization
183.62M
62 days until earnings call
SYRE
Price
$16.72
Change
-$0.42 (-2.45%)
Updated
Aug 28 closing price
Capitalization
1.01B
69 days until earnings call
Interact to see
Advertisement

CCCC vs SYRE

Header iconCCCC vs SYRE Comparison
Open Charts CCCC vs SYREBanner chart's image
C4 Therapeutics
Price$2.55
Change-$0.03 (-1.16%)
Volume$838.59K
Capitalization183.62M
Spyre Therapeutics
Price$16.72
Change-$0.42 (-2.45%)
Volume$298.69K
Capitalization1.01B
CCCC vs SYRE Comparison Chart in %
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. SYRE commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and SYRE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (CCCC: $2.55 vs. SYRE: $16.72)
Brand notoriety: CCCC and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 51% vs. SYRE: 54%
Market capitalization -- CCCC: $183.62M vs. SYRE: $1.01B
CCCC [@Biotechnology] is valued at $183.62M. SYRE’s [@Biotechnology] market capitalization is $1.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 3 TA indicator(s) are bullish while SYRE’s TA Score has 6 bullish TA indicator(s).

  • CCCC’s TA Score: 3 bullish, 5 bearish.
  • SYRE’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SYRE is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а -2.30% price change this week, while SYRE (@Biotechnology) price change was -0.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +15.09%, and the average quarterly price growth was +29.14%.

Reported Earning Dates

CCCC is expected to report earnings on Oct 30, 2025.

SYRE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($1.01B) has a higher market cap than CCCC($184M). SYRE (-28.179) and CCCC (-29.167) have similar YTD gains . CCCC has higher annual earnings (EBITDA): -109.63M vs. SYRE (-222.15M). SYRE has more cash in the bank: 527M vs. CCCC (215M). SYRE has less debt than CCCC: SYRE (0) vs CCCC (62.9M). CCCC has higher revenues than SYRE: CCCC (34.2M) vs SYRE (0).
CCCCSYRECCCC / SYRE
Capitalization184M1.01B18%
EBITDA-109.63M-222.15M49%
Gain YTD-29.167-28.179104%
P/E RatioN/A1.72-
Revenue34.2M0-
Total Cash215M527M41%
Total Debt62.9M0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCSYRE
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CBBYX6.72N/A
N/A
AB Relative Value Advisor
RFISX17.85N/A
N/A
Ranger Small Cap Institutional
DEQYX13.29N/A
N/A
BNY Mellon Global Equity Income - Y
SENAX54.66N/A
N/A
Allspring Mid Cap Growth Fund - Cl A
MKVHX16.79N/A
N/A
MFS International Large Cap Value R6

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-1.16%
BEAM - CCCC
48%
Loosely correlated
-0.06%
SYRE - CCCC
44%
Loosely correlated
-2.45%
OCUL - CCCC
44%
Loosely correlated
+1.62%
MGNX - CCCC
44%
Loosely correlated
-1.16%
KYMR - CCCC
44%
Loosely correlated
-1.21%
More

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with IDYA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
-2.45%
IDYA - SYRE
61%
Loosely correlated
-0.28%
CGON - SYRE
61%
Loosely correlated
+0.89%
BEAM - SYRE
58%
Loosely correlated
-0.06%
XNCR - SYRE
57%
Loosely correlated
+0.37%
CRNX - SYRE
56%
Loosely correlated
+0.82%
More